Antiplatelet Loading Before Carotid Artery Stenting
Patients undergoing carotid artery stenting should receive dual antiplatelet therapy (DAPT) with aspirin and clopidogrel, with clopidogrel loaded at 600 mg at least 2 hours before the procedure (or 300 mg at least 6 hours before), followed by maintenance doses of aspirin 75-100 mg daily and clopidogrel 75 mg daily for at least 1 month post-procedure. 1, 2
Loading Regimen Specifics
Clopidogrel Loading Dose
- Administer 600 mg loading dose at least 2 hours before CAS when the decision to proceed with stenting is confirmed 3, 2
- Alternatively, 300 mg can be given at least 6 hours before the procedure 2
- For patients already on clopidogrel 75 mg daily maintenance, give an additional 300-600 mg loading dose once CAS is planned 3, 2
Aspirin Dosing
- Initiate aspirin 75-325 mg daily before the procedure 4, 1
- After stent placement, maintain aspirin at 75-100 mg daily (lower doses preferred to minimize bleeding risk) 1, 5
Duration of DAPT
- Continue DAPT for at least 1 month after carotid stenting 1
- After 1 month, transition to long-term single antiplatelet therapy (aspirin or clopidogrel) indefinitely 1
Alternative P2Y12 Inhibitors
Prasugrel Considerations
Prasugrel is contraindicated in patients with prior stroke or TIA, which represents a significant limitation for carotid stenting patients 6
- In the TRITON-TIMI 38 trial, patients with prior TIA/stroke had stroke rates of 6.5% on prasugrel (including 2.3% intracranial hemorrhage) versus 1.2% on clopidogrel 6
- Given that many carotid stenting patients have symptomatic disease (prior stroke/TIA), prasugrel should generally be avoided in this population 6
Ticagrelor Evidence
- Recent registry data (2022) comparing ticagrelor versus clopidogrel in 17,731 transfemoral CAS patients showed no difference in stroke/death rates but significantly higher bleeding risk with ticagrelor (5.8% vs 2.8%, RR 2.0) 7
- However, when intraoperative protamine was used, bleeding rates equalized and ticagrelor showed potential benefit 7
- Clopidogrel remains the preferred P2Y12 inhibitor for carotid stenting due to its established safety profile and lower bleeding risk 8, 7
Clinical Context and Timing
When Anatomy is Unknown
- In patients with high probability of significant carotid disease, pretreatment with clopidogrel may be considered, though European guidelines give this a weak recommendation (Class IIb) 3
- The safest approach is to wait until coronary anatomy is confirmed before loading, as was done in major trials 6
Symptomatic vs Asymptomatic Patients
- For symptomatic carotid stenosis not undergoing revascularization, DAPT with aspirin and clopidogrel 75 mg is recommended for the first 21 days, followed by single antiplatelet therapy 1
- This differs from the stenting protocol where DAPT continues for at least 1 month post-procedure 1
Important Caveats and Pitfalls
Clopidogrel Resistance
- Approximately 36-43% of patients demonstrate clopidogrel resistance on platelet function testing 9
- Clopidogrel resistance is associated with increased periprocedural neurologic events after CAS 7, 9
- Consider adding cilostazol 200 mg daily to standard DAPT in clopidogrel-resistant patients to reduce ischemic complications (reduces new ischemic lesions from 25% to 5.6%) 9
Bleeding Risk Factors
- Patients <60 kg have increased bleeding risk and may require dose adjustment 6
- Avoid high-dose aspirin (>325 mg) as it increases bleeding without additional benefit 4, 5
- Never discontinue antiplatelet therapy abruptly in the first month post-stenting due to high risk of stent thrombosis 1
Comparison to Carotid Endarterectomy
- Do not confuse CAS protocols with carotid endarterectomy (CEA) protocols: CEA requires only single antiplatelet therapy perioperatively, not DAPT 10
- The requirement for DAPT is specific to stenting due to different thrombotic mechanisms 10